Global Serum-Free Media Market Report to 2032 - Extensive Adoption of Serum-Free Media in Biopharmaceutical Companies Presents Opportunities - ResearchAndMarkets.com

The "Global Serum-Free Media Market: Focus on Media Type, End User, and Region - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.

The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

Market Lifecycle Stage

The global serum-free media market is progressing rapidly with a significant increase in research and development activities pertaining to a wide range of animal component-free products for disease detection, accentuating their criticality in healthcare. Serum-free media has a critical role in the cellular diagnostics approach, as it ensures the safe and effective application for improved cell culture and cell therapy-based methods.

Increasing investments in R&D for cell-based diagnostics is one of the major opportunities in the serum-free media market. Several clinical organizations and biopharmaceutical companies are working collaboratively on molecular biology applications, cell biology, cancer research, metagenomics, and plant research using serum-free media as a therapeutic means for applications in several disease indications in order to enable efficient diagnosis, treatment selection, dosage selection, and treatment monitoring.

Impact

Several techniques are employed in the development of serum-free media utilization for the process of removing cells, tissues, or organs from an animal or plant and putting them into a setting that will help them survive and/or proliferate. The selection of an adequate growth medium for in vitro cultivation is the most significant and important phase in cell culture. A growth medium, also known as a culture media, is a solution, gel, or powder that promotes the development of cells, small plants, or microorganisms. This serum-free medium market space has been segmented into different media types that include common serum-free, xeno-free, chemically-defined, animal component-free, and protein-free.

Recent Developments in the Global Serum-Free Media Market

• In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics. This expansion would support the worldwide media supply and increase the capacity to create high-quality technologies.
• In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China. The new center would enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
• In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
• In April 2021, PromoCell GmbH launched an upgrade to its Keratinocyte Cell Culture Portfolio. The company expanded its improved animal-extract-free Keratinocyte Growth Medium 3 for the standardized isolation and development of juvenile and adult Normal Human Keratinocytes.
• In March 2021, the company also launched its improved third-generation Melanocyte Cell Culture Portfolio. Melanocyte Growth Medium M3 is a serum-free, bovine pituitary extract (BPE)-free, and phorbol myristate acetate (PMA)-free media formulation.

Market Dynamics

Drivers

• Low Risk of Contamination as a Demand Driver
• Launch of innovative products in Serum-Free Media Ecosystem
• Low reception cost involving small and medium enterprises in comparison to animal derived media

Restraints

• Slow Growth Rate in Comparison to Serum-Supplemented Media
• Requirement of Diverse Cell-Type for Specific Media Formulation

Opportunities

• Regulatory Bodies Across the Globe Encourage the Use of Animal-Free Media in Biological Products
• Extensive Adoption of Serum-Free Media in Biopharmaceutical Companies

Companies Mentioned

• MP BIOMEDICALS.
• Corning Incorporated
• FUJIFILM Holdings Corporation
• PAN-Biotech.
• PromoCell GmbH
• HiMedia Laboratories
• Danaher.
• Athena Environmental Sciences, Inc.
• Lonza Group AG
• Merck KgaA
• R&D Systems, Inc.
• Sartorius AG
• Sino Biological, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.

Market Segmentation

by Media Type

• Common Serum-Free
• Xeno-Free
• Chemically-Defined
• Animal Component-Free
• Protein-Free

by End User

• Biopharmaceutical Companies
• Academic and Research Organizations
• Clinical Research Organizations
• Others

by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

For more information about this report visit https://www.researchandmarkets.com/r/qys5tu

View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005789/en/